insights_auto
Why is SRPT up 3.71%?
Dive Deeperchevron_right
SRPT:NASDAQ
Sarepta Therapeutics Inc
$17.74
arrow_upward
+3.71%(+0.64) 1D
Oct 19, 1:17:56 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SRPT...
Open
$17.25
High
$17.83
Low
$17.12
Mkt. cap
1.87B
Avg. vol.
3.17M
Volume
830.48K
52-wk high
$24.68
52-wk low
$14.68
EPS
-$1.66
Beta
0.38
Shares outstanding
105.63M
No. of employees
835
Open
$17.25
High
$17.83
Low
$17.12
Mkt. cap
1.87B
Avg. vol.
3.17M
Volume
830.48K
52-wk high
$24.68
52-wk low
$14.68
EPS
-$1.66
Beta
0.38
Shares outstanding
105.63M
No. of employees
835
News stories
From web sources and news partners
Investing.com
·
4 hours ago
H.C. Wainwright reiterates Sarepta stock Sell rating at $5 target
ad-hoc-news.de
·
1 day ago
Sarepta presents 80 percent DM1 data for Sarepta Therapeutics stock
Profile
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
About Sarepta Therapeutics Inc